A Reciprocal Interaction between Immune Reconstitution and Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation

Background Hemorrhagic cystitis (HC) is one of the serious complications of allogeneic hematopoietic stem cell transplants (allo-HSCT), with the potential to cause significant morbidity. However, the underlying mechanism of HC is not yet clear. Objective To explore the reciprocal interaction between...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 132; no. Supplement 1; p. 4962
Main Authors Xiao, Min, Luo, Xiaofeng, Ren, Jinhua, Yang, Xiaozhu, Zhu, Haojie, Lin, Kangni, Chen, Minmin, Chen, Shaozhen, Li, Qian, Chen, Zhizhe, Hu, Jianda, Yang, Ting
Format Journal Article
LanguageEnglish
Published Elsevier Inc 29.11.2018
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Hemorrhagic cystitis (HC) is one of the serious complications of allogeneic hematopoietic stem cell transplants (allo-HSCT), with the potential to cause significant morbidity. However, the underlying mechanism of HC is not yet clear. Objective To explore the reciprocal interaction between immune reconstitution and HC after allo-HSCT. Methods 101 patients undergoing allo-HSCT in our department during July, 2014 to April, 2017 were analyzed. JC virus(JCV), BK virus (BKV), cytomegalovirus (CMV) by quantitative real-time PCR were performed on all blood or urine samples post-HSCT. Non-specific T and B cell immune reconstitution were assessed by the expression of CD3, CD4, CD8, CD56, CD10, CD19, CD20 and CD22 with multiparametric flow cytometry, and specific T cell phenotype and cytokine production were determined by the expression of CD3, CD4, CD8, CD69, IL-2, IFN-gamma and TNF-alpha on PBMCs after the stimulation with one of four BKV peptides (tAg,Tag,VP-1,VP-2,VP-3). Results 62 out of total 101 patients were male and 39 were female. The median age was 27 years (range, 1-54). 85 patients were diagnosed as malignancy hematologic disease (AML=44, ALL=26, MDS=4, CML=6, NHL=5), while 16 were non-malignancy hematologic disease (SAA = 14, fanconi=1, thalassemia=1). Through the cox regression analysis, the hazard ratio (HR) of HC (95% confidence interval) for BKV viruria was 4.866 (1.908-12.406), with a P-value of 0.001. Those with primary malignance disease also had higher odds of developing HC, with an HR of 5.101. Both of them were independent risk factors in multivariate analysis. There was no significant difference on the expression of CD3, CD4, CD8 and CD56 representative the non-specific T cell immune reconstitution between BK+ and BK- group, but the non-specific B cell immune reconstitution stained with CD19+, CD20+, CD22+ was significant delayed in BK+ group. Moreover, the specific T cell immune reconstitution performed in 6 cases were significant delayed in BK+ group as well compared to that in BK- group. Conclusion HC is correlated to BKV viruria and primary malignance disease in allo-HSCT. Poor specific immune reconstitution post-HSCT increased the risk of BK virus reactivation, and BK virus infection delayed the immune reconstitution after transplantation vise versa. No relevant conflicts of interest to declare.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2018-99-118937